Trial Search Results

Single Session Class to Reduce Opioid Use in Chronic Pain

Prescription opioids are one of the most commonly used treatments for chronic pain, despite limited evidence of their efficacy and high morbidity and mortality risks. The study aims to determine the efficacy of a targeted single-session psychology class in reducing opioid use among patients with chronic pain. The information gained from this study has the potential to identify patients who achieve a meaningful reduction in opioid use and inform opioid reduction strategies.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: National Institute on Drug Abuse (NIDA)

Stanford Investigator(s):

Intervention(s):

  • Behavioral: Pain Catastrophizing Class
  • Behavioral: Health Education

Phase:

N/A

Eligibility


Inclusion Criteria:

   - 18-80 years of age

   - Diagnosis of chronic non-cancer pain (> 3 months in duration)

   - Currently using prescription opioids ≥ 20mg morphine equivalent daily dose (MEDD) for
   ≥ 3 months;

   - Ability and willingness to complete study procedures.

Exclusion Criteria:

   - Open litigation regarding a medical condition

   - Inability to provide informed consent and complete study procedures

   - Active suicidality.

Ages Eligible for Study

18 Years - 80 Years

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Maisa Ziadni
313-725-0615
Recruiting